19-Oct-2026 19:53:27
ROSSARI BIOTECH Q2 CONCALL : MID-TO-HIGH-TEEN REVENUE GROWTH, FY28 MARGIN EXPANSION & SAUDI ARABIA MANUFACTURING PLANS
• FY27 REVENUE GROWTH EXPECTED IN MID-TO-HIGH TEENS • FY27 EBITDA MARGIN EXPECTED AROUND 12%; MEANINGFUL IMPROVEMENT ANTICIPATED FROM FY28 • EXPORT CONTRIBUTIO…